Both in Pharmaceuticals
Canopy Growth vs ARS Pharmaceuticals
Over the past year CGC returned −41.1% and SPRY returned −64.6%; their daily moves had a correlation of 0.09.
CGC −41.1% SPRY −64.6%Growth of $1, one year, split-adjusted
| Metric | CGC | SPRY |
|---|---|---|
| Price | $0.7067 | $3.05 |
| Market cap | $299.0M | $303.3M |
| Today | +3.80% | 0.00% |
| 1 month | −20.1% | −28.9% |
| 6 months | −34.6% | −66.2% |
| Year to date | −38.0% | −73.8% |
| 1 year | −43.0% | −66.0% |
| Revenue growth (YoY) | +7.8% | +114.2% |
| Gross margin | 27.4% | 61.8% |
| Net margin | −18.0% | −185.2% |
| P/E (TTM) | — | — |
| Price / sales | 1.2× | 2.6× |
| Net cash | $67.9M | -$27.8M |
| Dividend yield | — | — |
| Volatility (60d) | 41.8% | 70.0% |
| Short % of float | 7.5% | 40.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).